The list of technologies used to find
and validate fragments is long, with more than a dozen in our 2024 poll. But it’s
always fun to learn about new approaches. At the Novalix conference earlier
this year I learned of “focal molography,” and this is the topic of a recent
paper in J. Med. Chem. by Nicholas Favalli, Andreas Frutiger, Sebastian
Oehler, and colleagues at Philochem and lino Biotech.
The approach is described in detail
in this Wikipedia article. Briefly, it
is a biophysical technique based on changes in diffraction. A sensor chip
contains a matrix of “molograms,” each of which is a lens constructed of
micropatterned ridges and grooves. The ridges of each mologram are functionalized
with unique single-stranded oligonucleotides. These capture complementary
strands, each attached to a molecule to be screened. The grooves are coated
with oligonucleotides without small molecules to act as a control in the subsequent readout. Proteins
are then flowed over the chip. Protein binding to the small molecules of a
specific mologram changes the topography of the ridge, and so the diffraction.
This change can be measured in units of “coherent mass density” (pg/mm2). Because only specific binding to the ridges is
detected (the grooves provide background controls for each mologram), the
technique is suitable for even crude samples such as cell lysates.
An obvious application for focal
molography is to confirm the binding of hits identified from DNA-encoded
libraries (DEL), since the small molecules already have an oligonucleotide tag.
This is the focus of the new paper.
The researchers started by assessing
three known binders to the model protein carbonic anhydrase IX (CAIX). Surface
plasmon resonance (SPR), the most frequently-used chip-based biophysical
method, was used as a benchmark in two formats, one in which the small molecule
was bound to the SPR chip, which is most comparable to focal molography, and
one in which the protein was bound to the SPR chip.
SPR and focal molography agreed
in rank order for the three compounds, but focal molography sometimes suggested
tighter binding. For the highest-affinity compound, SPR gave a Kd of
28 nM for compound bound to the chip and 450-750 nM for protein bound to the
chip, while focal molography gave a Kd of 0.82 nM. Agreement was better
for the weaker binders, one of which was mid-nanomolar and the other low
micromolar. The kinetic constants kon and koff
also differed between focal molography and SPR by as much as two orders of
magnitude.
Next, the researchers examined hits
from a DEL screen against CAIX, some of which were selective against the related
protein CAII. A total of two dozen molecules were tested by both focal
molography and fluorescence polarization (FP) as an orthogonal technique. Again,
the rank orders of affinities for the compounds to CAIX and CAII agreed while the
absolute values varied, with focal molography usually suggesting ten-fold
tighter binding. (Though the FP assay often bottomed out above the Kd
values measured by focal molography.)
Finally, the researchers examined
the binding of a known high-affinity binder to the oncology target fibroblast
activation protein (FAP). In this case the measured affinities were close to
the reported value.
This is an interesting approach,
and according to the researchers “focal molography can support up to ~500
duplicate kinetic measurements per day on a single regenerable chip.” The observation
that affinity measurements seem to be tighter than other methods does raise concerns.
I wonder if the density of the molecules on the molograms leads to rebinding, as is sometimes seen when SPR chips are too
heavily functionalized. Alternatively, since CAIX is a homodimer, perhaps avidity effects played a role. Also, the researchers suggest that the technique is
best used for compounds with affinities better than 10 µM, which reduces
utility for many fragment programs.
If you’ve used focal molography,
how has it worked for you?
No comments:
Post a Comment